Why Perform Colonoscopy in Ovarian Carcinoma
Colonoscopy in ovarian carcinoma serves two critical purposes: excluding colorectal cancer masquerading as ovarian cancer (which occurs in approximately 4-6% of cases) and identifying bowel involvement that may require surgical resection during cytoreductive surgery. 1, 2
Primary Indication: Excluding Gastrointestinal Primary Malignancy
The most important reason to perform colonoscopy is to rule out colorectal cancer metastatic to the ovary, particularly in mucinous ovarian tumors. When evaluating a suspected ovarian mass with mucinous histology:
- Measure serum CEA and CA 19-9 in addition to CA-125 1, 3
- Perform colonoscopy and/or gastroscopy when the CA-125/CEA ratio is ≤25 1
- Studies show that 4-6% of presumed ovarian cancers are actually colorectal cancers metastatic to the ovary 2, 4
This distinction is critical because it fundamentally changes treatment approach, prognosis, and surgical planning—treating metastatic colorectal cancer as primary ovarian cancer would result in inappropriate therapy and worse outcomes.
Secondary Indication: Assessing Bowel Involvement for Surgical Planning
Colonoscopy can identify bowel involvement requiring resection during cytoreductive surgery, though its utility here is more limited:
Predictive Value for Bowel Resection
- Complete obstruction on colonoscopy carries a relative risk of 4.29 for bowel resection and 4.38 for stoma creation 2
- Extrinsic compression has a relative risk of 3.16 for bowel resection and 3.21 for stoma 2
- Moderate limited patency shows relative risk of 5.14 for bowel resection and 4.17 for stoma 2
Important Limitations
However, colonoscopy has significant limitations for detecting serosal/peritoneal involvement:
- Sensitivity is only 44% for identifying bowel infiltration 4
- Specificity is high at 100%, but the low sensitivity means many cases requiring bowel resection are missed 4
- Intraoperative assessment remains the primary determinant for colorectal interventions 5
Recent data from 2025 shows that even when abnormal colonoscopic findings were present in 38.8% of advanced ovarian cancer cases, colorectal resections were performed in only 53% of these patients, with moderate sensitivity (67%) and specificity (74%) 5.
Clinical Algorithm for Colonoscopy Decision-Making
Perform colonoscopy when:
- Mucinous histology is suspected or confirmed (mandatory to exclude GI primary)
- CA-125/CEA ratio ≤25 (suggests possible GI origin)
- Symptoms suggesting bowel obstruction (abdominal pain, constipation, change in bowel habits)
- CT imaging shows bowel wall thickening or mass that could represent primary colorectal cancer
Colonoscopy may be deferred when:
- High-grade serous carcinoma with typical imaging findings
- Elevated CA-125 with normal CEA and CA 19-9
- No clinical or radiographic evidence of bowel involvement
- Patient already scheduled for primary cytoreductive surgery where intraoperative assessment will guide bowel resection decisions
Critical Caveats
- CT imaging with rectal contrast can increase sensitivity for detecting rectosigmoid serosal implants and may be an alternative to colonoscopy in some cases 6
- The primary role of colonoscopy is diagnostic (excluding GI primary), not surgical planning, as intraoperative findings ultimately determine the need for bowel resection 5
- Colonoscopy identified adenomas in 20% of ovarian cancer patients in one study, though this doesn't represent an increased prevalence compared to the general population 4
- Do not delay definitive surgery for colonoscopy in patients with clear advanced ovarian cancer and no suspicion of GI primary
The evidence strongly supports selective rather than routine use of colonoscopy, prioritizing cases where distinguishing primary site of malignancy impacts treatment strategy and survival outcomes.